Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Mar 15, 2016 at 10:20 AM EDT

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be…

Chris Lange | Mar 15, 2016 at 10:05 AM EDT

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Valeant Pharmaceuticals International reported mixed preliminary fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Chris Lange | Mar 14, 2016 at 12:50 PM EDT

Vericel Trips Over Earnings

Vericel Corp. (NASDAQ: VCEL) reported its fourth-quarter financial results before the markets opened on Monday. The company said it had…

Chris Lange | Mar 14, 2016 at 10:50 AM EDT

Senseonics Gears Up for IPO

Senseonics Holdings has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).…

Chris Lange | Mar 14, 2016 at 10:10 AM EDT

What to Expect From Valeant Pharma Q4 Earnings

Valeant Pharmaceuticals is scheduled to report its fourth-quarter preliminary results and update its 2016 financial guidance in a conference call…

Chris Lange | Mar 14, 2016 at 8:40 AM EDT

GW Pharma Explodes on Positive Late-Stage Results

GW Pharmaceuticals has announced the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex for…

Chris Lange | Mar 13, 2016 at 10:35 AM EDT

5 Key FDA Decisions Expected in March

24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the…

Chris Lange | Mar 11, 2016 at 12:05 PM EST

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) scored a win in a late-stage trial for the treatment of rheumatoid arthritis (RA). The…

Chris Lange | Mar 11, 2016 at 10:45 AM EST

Corvus Pharma Releases Expected Pricing Range in IPO

Corvus Pharmaceuticals expects to price more than 4 million shares in the range of $15 to $17 apiece in an…

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Mar 10, 2016 at 8:05 AM EST

Short Sellers Back Off of Major Biotechs

The February 29 short interest data have been compared with the previous report, and short interest decreased across the board…

Douglas A. McIntyre | Mar 10, 2016 at 6:39 AM EST

Valeant CEO Michael Pearson Should Resign

Valeant Pharmaceuticals International CEO Michael Pearson needs to leave the company he leads, as its problems continue to grow rapidly.

Chris Lange | Mar 9, 2016 at 11:50 AM EST

Amarin Reaches Settlement Terms With FDA

Amarin made some headway in Wednesday's regular trading session following a settlement with the U.S. Food and Drug Administration.

Lee Jackson | Mar 8, 2016 at 9:25 AM EST

Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week

With biotechs still way out of favor, investors need to be cautious, as often these companies are dependent on binary…

1 … 219 220 221 222 223 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Jefferies Top Drug Stocks for the Rest of 2016

Vericel Trips Over Earnings

Senseonics Gears Up for IPO

What to Expect From Valeant Pharma Q4 Earnings

GW Pharma Explodes on Positive Late-Stage Results

5 Key FDA Decisions Expected in March

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Corvus Pharma Releases Expected Pricing Range in IPO

Major Pharma Short Interest Takes a Small Step Back

Short Sellers Back Off of Major Biotechs

Valeant CEO Michael Pearson Should Resign

Amarin Reaches Settlement Terms With FDA

Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Jefferies Top Drug Stocks for the Rest of 2016

Vericel Trips Over Earnings

Senseonics Gears Up for IPO

What to Expect From Valeant Pharma Q4 Earnings

GW Pharma Explodes on Positive Late-Stage Results

5 Key FDA Decisions Expected in March

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Corvus Pharma Releases Expected Pricing Range in IPO

Major Pharma Short Interest Takes a Small Step Back

Short Sellers Back Off of Major Biotechs

Valeant CEO Michael Pearson Should Resign

Amarin Reaches Settlement Terms With FDA

Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income